Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (ChIPseq)

ABSTRACT: Three triple negative breast cancer cell lines (MDAMB231, SUM159, and HCC1806) were treated with small molecule inhibitors (JQ1, BET bromodomain inhibitor; GSK2801, BAZ2A/B bromodomain inhibitor) or BAZ siRNA alone and in combination with JQ1 for 48 hours

ORGANISM(S): Homo sapiens

PROVIDER: GSE116879 | GEO | 2019/07/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq)

Project description:Three triple negative breast cancer cell lines (MDAMB231, SUM159, and HCC1806) were treated with small molecule inhibitors (JQ1, BET bromodomain inhibitor; GSK2801, BAZ2A/B bromodomain inhibitor) alone and in combination for 72 hours

2019-07-09 | GSE116907 | GEO

Baz2a

Project description:Rattus norvegicus Baz2a, bromodomain adjacent to zinc finger domain, 2A [Source:RGD Symbol;Acc:1305037], is differentially expressed in 14 experiment(s);

| ENSRNOG00000053881 | ExpressionAtlas

Baz2a

Project description:Rattus norvegicus Baz2a, bromodomain adjacent to zinc finger domain, 2A [Source:RGD Symbol;Acc:1305037], is expressed in 5 baseline experiment(s);

| ENSRNOG00000053881 | ExpressionAtlas

Effects of BRD4 inhibition in AML

Project description:The BET (bromodomain and extra terminal) protein family members including BRD4 bind to acetylated lysines on histones and regulate the expression of important oncogenes, e.g., MYC and BCL2. Here we demonstrate the sensitizing effects of the histone hyperacetylation inducing pan-histone deacetylase inhibitor (HDI) panobinostat (PS) on human AML blast progenitor cells (BPCs) to the BET protein inhibitor JQ1. Treatment with JQ1 but not its inactive enantiomer (R-JQ1) was highly lethal against AML BPCs expressing mutant NPM1c+ with or without co-expression of FLT3-ITD, or AML expressing MLL fusion oncoprotein. JQ1 treatment reduced binding of BRD4 and RNA polymerase II to the DNA of MYC and BCL2, and reduced their levels in the AML cells. Co-treatment with JQ1 and the HDAC inhibitor panobinostat (PS) synergistically induced apoptosis of the AML BPCs, but not of normal CD34+ hematopoietic progenitor cells. This was associated with greater attenuation of MYC and BCL2, while increasing p21, BIM and cleaved PARP levels in the AML BPCs. Co-treatment with JQ1 and PS significantly improved the survival of the NOD/SCID mice engrafted with OCI-AML3 or MOLM13 cells (p < 0.01). These findings highlight co-treatment with a BRD4 antagonist and an HDI as a potentially efficacious therapy of AML. Two samples were analyzed (untreated cells, cells treated with JQ1)

2014-01-01 | E-GEOD-51950 | biostudies-arrayexpress

BAZ2A

Project description:Macaca mulatta BAZ2A, bromodomain adjacent to zinc finger domain 2A [Source:VGNC Symbol;Acc:VGNC:70232], is differentially expressed in 1 experiment(s);

| ENSMMUG00000019332 | ExpressionAtlas

BAZ2A

Project description:Macaca mulatta BAZ2A, bromodomain adjacent to zinc finger domain 2A [Source:VGNC Symbol;Acc:VGNC:70232], is expressed in 3 baseline experiment(s);

| ENSMMUG00000019332 | ExpressionAtlas

Baz2a

Project description:Mus musculus Baz2a, bromodomain adjacent to zinc finger domain, 2A [Source:MGI Symbol;Acc:MGI:2151152], is differentially expressed in 78 experiment(s);

| ENSMUSG00000040054 | ExpressionAtlas

BAZ2A

Project description:Equus caballus BAZ2A, bromodomain adjacent to zinc finger domain 2A [Source:VGNC Symbol;Acc:VGNC:15775], is expressed in 1 baseline experiment(s);

| ENSECAG00000018243 | ExpressionAtlas

BAZ2A

Project description:Homo sapiens BAZ2A, bromodomain adjacent to zinc finger domain 2A [Source:HGNC Symbol;Acc:HGNC:962], is expressed in 44 baseline experiment(s);

| ENSG00000076108 | ExpressionAtlas

BAZ2A

Project description:Homo sapiens BAZ2A, bromodomain adjacent to zinc finger domain 2A [Source:HGNC Symbol;Acc:HGNC:962], is differentially expressed in 159 experiment(s);

| ENSG00000076108 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data